What is a stock summary page? Click here for an overview.
Business Description

Spexis AG
ISIN : CH0106213793
Share Class Description:
STU:29Y: Registered SharesCompare
Compare
Traded in other countries / regions
SPEX.Switzerland29Y.GermanySPEXz.UKPPHOF.USA IPO Date
2018-05-16Description
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spexis AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.39 | ||
Beta | - | ||
3-Year Sharpe Ratio | -14.91 | ||
3-Year Sortino Ratio | -3.38 | ||
Volatility % | - | ||
14-Day RSI | - | ||
14-Day ATR (€) | - | ||
20-Day SMA (€) | 10.36 | ||
12-1 Month Momentum % | - | ||
52-Week Range (€) | 10.36 - 10.36 | ||
Shares Outstanding (Mil) | 67.66 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Spexis AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Spexis AG Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Spexis AG Frequently Asked Questions
What is Spexis AG(STU:29Y)'s stock price today?
The current price of STU:29Y is €10.36. The 52 week high of STU:29Y is €10.36 and 52 week low is €10.36.
When is next earnings date of Spexis AG(STU:29Y)?
The next earnings date of Spexis AG(STU:29Y) is .
Does Spexis AG(STU:29Y) pay dividends? If so, how much?
Spexis AG(STU:29Y) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |